Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSF1 | Q00613 | 15/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL3060651 | 0.75 | HSF1 (0.57) | HSF1TSHRATMCYP2D6CYP2C19 | |
| Hydrochloric Acid SCHEMBL3060654 | 0.75 | HSF1 (0.57) | HSF1TSHRATMCYP2D6CYP2C19 | |
| SCHEMBL30237248 | 0.75 | HSF1 (0.56) | HSF1POLBTSHRATMACE2 | |
| SCHEMBL30237178 | 0.73 | HSF1 (0.55) | HSF1POLBTSHRATMCYP2D6 | |
| SCHEMBL3060503 | 0.73 | HSF1 (0.60) | HSF1POLBTSHRATMACE2 | |
| SCHEMBL3060495 | 0.73 | HSF1 (0.60) | HSF1POLBTSHRATMACE2 | |
| SCHEMBL6009203 | 0.72 | HSF1 (0.65) | HSF1TSHRCYP2D6 | |
| SCHEMBL6009202 | 0.72 | HSF1 (0.65) | HSF1TSHRCYP2D6 | |
| Hydrochloric Acid SCHEMBL3076170 | 0.72 | HSF1 (0.64) | HSF1TSHRCYP2D6CYP2C19 | |
| Hydrochloric Acid SCHEMBL3076169 | 0.72 | HSF1 (0.64) | HSF1TSHRCYP2D6CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4408533-A1 | OXIMES AND THEIR USE IN TREATMENT OF GBA-RELATED DISEASES | Zevra Denmark A/S (DK) | 2024-08-07 | — | — | EP | disclosed |
| WO-2023053008-A1 | OXIMES AND THEIR USE IN TREATMENT OF GBA-RELATED DISEASES | KEMPHARM DENMARK A/S (DK) | 2023-04-06 | — | — | WO | disclosed |